US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

325.90

-0.8700-0.27%

Post-market: 325.900.00000.00%19:47 EDT

Volume:348.07K

Turnover:113.72M

Market Cap:38.78B

PE:74.00

High:331.52

Open:329.50

Low:324.92

Close:326.77

52wk High:385.22

52wk Low:253.95

Shares:119.00M

Float Shares:85.45M

Volume Ratio:0.73

T/O Rate:0.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):4.40

EPS(LYR):2.47

ROE:12.42%

ROA:5.96%

PB:8.15

PE(LYR):131.94

Loading ...

Overview Company News Filings

Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks

BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market

BeOne Medicines to Invest $300 Million to Expand US Drug Manufacturing

MT Newswires Live

Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial

3 U.S. Drug Manufacturing Stocks Investors Are Watching As Tariffs Rise

Simply Wall St.

Press Release: Beone Medicines to Announce Second Quarter 2026 Financial Results on August 5

BeOne Medicines (ONC) Stock Looks Expensive Even With Strong Pipeline Hopes

Simply Wall St.

How Chemotherapy-Free Phase 3 MCL Success At BeOne Medicines (ONC) Has Changed Its Investment Story

Simply Wall St.

BeOne Medicines (ONC) Gets a Buy from Barclays

BeOne Medicines Advances Sonrotoclax Formulation Study, Signaling Progress in ONC Pipeline

BeOne Medicines treatment of pancreatic cancer granted orphan status

BEIGENE Awards Aggregate 33,400 Restricted Stock Units Represented by American Depositary Shares

BEIGENE Shares Surge Over 4% on Positive Phase 3 Clinical Trial News for Zanubrutinib

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), BeOne Medicines (ONC) and Zevra Therapeutics (ZVRA)

BEIGENE Reports Positive Phase 3 Trial Results for BRUKINSA® in First-Line Treatment of Mantle Cell Lymphoma

BeOne Medicines' Potential Chemotherapy-Free Lymphoma Treatment Meets Primary Endpoint in Phase 3 Study

MT Newswires Live

Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI

BEIGENE Subsidiary to Pay Approximately 446 Million Yuan in Back Taxes, No Penalty Involved

BeOne Medicines’ Real‑World Lung Cancer Study Puts Tislelizumab Under the Market Microscope

BeOne Medicines (ONC) Investors Track New Data from BeiGene’s Chronic Urticaria Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ONC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","latestPrice":325.9,"timestamp":1784923200000,"preClose":326.77,"halted":0,"volume":348068,"hourTrading":{"tag":"盘后","latestPrice":325.9,"preClose":325.9,"latestTime":"19:47 EDT","volume":2883,"amount":939548.82,"timestamp":1784936825607,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.002662423111056721,"floatShares":85446200,"shares":119000000,"eps":4.404108,"marketStatus":"Market Closed","change":-0.87,"latestTime":"07-24 16:00:00 EDT","open":329.5,"high":331.52,"low":324.92,"amount":113717846.22744001,"amplitude":0.020198,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.404108,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":326.77,"preHourTrading":{"tag":"盘前","latestPrice":333.248,"preClose":326.77,"latestTime":"08:28 EDT","volume":48729,"amount":15924061.22322,"timestamp":1784896125289,"change":6.478,"changeRate":0.019824,"amplitude":0.034483},"postHourTrading":{"tag":"盘后","latestPrice":325.9,"preClose":325.9,"latestTime":"19:47 EDT","volume":2883,"amount":939548.82,"timestamp":1784936825607,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7299315379574403,"impliedVol":0.4176,"impliedVolPercentile":0.3586},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":85446200,"roa":"5.96%","roe":"12.42%","lyrEps":2.469999,"volumeRatio":0.7299315379574403,"shares":119000000,"dividePrice":0,"high":331.52,"amplitude":0.020198,"preClose":326.77,"low":324.92,"week52Low":253.9475,"pbRate":"8.15","psRate":"6.76","week52High":385.22,"institutionHeld":0,"latestPrice":325.9,"eps":4.404108,"divideRate":0,"volume":348068,"delay":0,"ttmEps":4.404108,"open":329.5,"prevYearClose":303.81,"prevWeekClose":312.02,"prevMonthClose":284.97,"prevQuarterClose":284.97,"fiveDayClose":312.02,"twentyDayClose":275.34,"sixtyDayClose":298.16,"earningDate":1785859200000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2026-08-05","symbol":"ONC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":1.4,"defaultRemindTime":1785960000000,"name":null,"time":"Post Market","dateTimestamp":1785902400000,"actualEps":null},{"market":"US","date":"2026-05-06","symbol":"ONC","fiscalQuarterEnding":"2026/03","expectedEps":0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":1.96},{"market":"US","date":"2026-02-26","symbol":"ONC","fiscalQuarterEnding":"2025/12","expectedEps":1.6,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":0.58},{"market":"US","date":"2025-11-06","symbol":"ONC","fiscalQuarterEnding":"2025/09","expectedEps":0.72,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":1.09},{"date":"2025-08-30","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756540800000,"name":null,"time":"Pre-Market","dateTimestamp":1756526400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.6786,"hold":0,"sell":0.0357,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6786,"analysts":28,"updateTime":1783915200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2026-07-24","current":73.999094,"percent":0.774074,"low":-217.585346,"twenty":-74.11053,"median":-28.275697,"eighty":112.626442,"high":609.337035,"avg":43.340558,"sd":215.545822,"marketCap":36328336476},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820},{"date":"2025-06-13","current":-89.808695,"twenty":-44.177303,"median":-38.271158,"eighty":-22.941372,"marketCap":35237878321},{"date":"2025-06-20","current":-76.439732,"twenty":-44.40516,"median":-38.484462,"eighty":-23.038971,"marketCap":29992352055},{"date":"2025-06-27","current":-76.95683,"twenty":-44.800569,"median":-38.641761,"eighty":-23.063278,"marketCap":30195243589},{"date":"2025-07-03","current":-74.11053,"twenty":-45.138397,"median":-38.836841,"eighty":-23.158686,"marketCap":29078452032},{"date":"2025-07-11","current":-76.495446,"twenty":-45.905367,"median":-39.006759,"eighty":-23.171606,"marketCap":30014212230},{"date":"2025-07-18","current":-87.653233,"twenty":-47.435675,"median":-39.313748,"eighty":-23.176246,"marketCap":34392148550},{"date":"2025-07-25","current":-89.648478,"twenty":-48.541013,"median":-39.640999,"eighty":-23.189441,"marketCap":35175014575},{"date":"2025-08-01","current":-91.060669,"twenty":-60.626235,"median":-39.865155,"eighty":-23.250607,"marketCap":35729110635},{"date":"2025-08-08","current":-184.757225,"twenty":-63.824658,"median":-40.051934,"eighty":-23.50984,"marketCap":32820458238},{"date":"2025-08-15","current":-191.818248,"twenty":-64.911375,"median":-40.112152,"eighty":-23.522344,"marketCap":34074785315},{"date":"2025-08-22","current":-194.469228,"twenty":-72.041871,"median":-40.222554,"eighty":-23.535152,"marketCap":34545708113},{"date":"2025-08-29","current":-184.552827,"twenty":-72.8475,"median":-40.343171,"eighty":-23.581122,"marketCap":32784148770},{"date":"2025-09-05","current":-197.417514,"twenty":-73.864189,"median":-40.425269,"eighty":-23.723244,"marketCap":35069444682},{"date":"2025-09-12","current":-208.147892,"twenty":-74.224679,"median":-40.801852,"eighty":-23.82061,"marketCap":36975599617},{"date":"2025-09-19","current":-212.503459,"twenty":-75.66857,"median":-40.932054,"eighty":-23.865007,"marketCap":37749326897},{"date":"2025-09-26","current":-203.715512,"twenty":-76.587723,"median":-41.008162,"eighty":-23.928977,"marketCap":36188227257},{"date":"2025-10-03","current":-213.916471,"twenty":-77.910534,"median":-41.112345,"eighty":-23.950329,"marketCap":38000335866},{"date":"2025-10-10","current":-208.109485,"twenty":-81.639564,"median":-41.598105,"eighty":-24.044918,"marketCap":36968777077},{"date":"2025-10-17","current":-197.090466,"twenty":-85.2662,"median":-41.668284,"eighty":-24.084563,"marketCap":35011347487},{"date":"2025-10-24","current":-192.138725,"twenty":-87.584871,"median":-41.753651,"eighty":-24.09529,"marketCap":34131715179},{"date":"2025-10-31","current":-191.016991,"twenty":-89.061223,"median":-41.811067,"eighty":-24.120226,"marketCap":33932449287},{"date":"2025-11-07","current":-207.03708,"twenty":-89.680521,"median":-41.96845,"eighty":-24.175905,"marketCap":36778273935},{"date":"2025-11-14","current":594.631071,"twenty":-89.43801,"median":-41.811067,"eighty":-24.044918,"marketCap":40761959883},{"date":"2025-11-21","current":563.847015,"twenty":-89.201535,"median":-41.753651,"eighty":-23.82061,"marketCap":38651712910},{"date":"2025-11-28","current":549.835185,"twenty":-89.104768,"median":-41.685343,"eighty":-23.530029,"marketCap":37691201965},{"date":"2025-12-05","current":534.967794,"twenty":-89.063642,"median":-41.61723,"eighty":-23.184163,"marketCap":36672042310},{"date":"2025-12-12","current":517.921144,"twenty":-88.590694,"median":-41.129457,"eighty":-23.039198,"marketCap":35503494432},{"date":"2025-12-19","current":495.611986,"twenty":-88.19516,"median":-41.047814,"eighty":-22.787779,"marketCap":33974201659},{"date":"2025-12-26","current":503.21518,"twenty":-87.945005,"median":-40.950457,"eighty":-22.473183,"marketCap":34495400571},{"date":"2026-01-02","current":490.430192,"twenty":-87.636143,"median":-40.899758,"eighty":-22.105685,"marketCap":33618989662},{"date":"2026-01-09","current":517.162439,"twenty":-87.22937,"median":-40.570085,"eighty":-21.930759,"marketCap":35451485198},{"date":"2026-01-16","current":546.090088,"twenty":-85.828543,"median":-40.382553,"eighty":-21.503627,"marketCap":37434475537},{"date":"2026-01-23","current":546.929506,"twenty":-85.639801,"median":-40.307741,"eighty":-21.22036,"marketCap":37492017667},{"date":"2026-01-30","current":564.993144,"twenty":-85.550958,"median":-40.153659,"eighty":-20.966373,"marketCap":38730280050},{"date":"2026-02-06","current":560.150346,"twenty":-85.195011,"median":-40.102874,"eighty":-20.825389,"marketCap":38398306221},{"date":"2026-02-13","current":559.214072,"twenty":-84.275105,"median":-39.916618,"eighty":-20.627155,"marketCap":38334124614},{"date":"2026-02-20","current":572.225057,"twenty":-83.309792,"median":-39.846883,"eighty":-20.486836,"marketCap":39226027634},{"date":"2026-02-27","current":124.64483,"twenty":-82.630374,"median":-39.542215,"eighty":-20.122622,"marketCap":35764714896},{"date":"2026-03-06","current":113.265677,"twenty":-81.639564,"median":-39.274234,"eighty":-19.815709,"marketCap":32499660582},{"date":"2026-03-13","current":110.254986,"twenty":-80.905934,"median":-38.936161,"eighty":-19.52935,"marketCap":31635793773},{"date":"2026-03-20","current":109.257937,"twenty":-80.698984,"median":-38.812817,"eighty":-19.378455,"marketCap":31349707731},{"date":"2026-03-27","current":107.028105,"twenty":-78.593786,"median":-38.554628,"eighty":106.63856,"marketCap":30709895147},{"date":"2026-04-02","current":119.197503,"twenty":-77.951,"median":-38.396659,"eighty":109.305857,"marketCap":34201697271},{"date":"2026-04-10","current":121.122038,"twenty":-77.761122,"median":-38.192039,"eighty":109.972102,"marketCap":34753909865},{"date":"2026-04-17","current":123.949552,"twenty":-77.38927,"median":-37.882149,"eighty":113.865362,"marketCap":35565216938},{"date":"2026-04-24","current":115.875632,"twenty":-77.050014,"median":-37.033118,"eighty":115.720164,"marketCap":33248542844},{"date":"2026-05-01","current":114.357667,"twenty":-76.68,"median":-35.397875,"eighty":115.720164,"marketCap":32812988374},{"date":"2026-05-08","current":68.695502,"twenty":-76.462018,"median":-34.468285,"eighty":115.560959,"marketCap":35242166242},{"date":"2026-05-15","current":66.012693,"twenty":-76.246744,"median":-33.418249,"eighty":115.518333,"marketCap":33865831800},{"date":"2026-05-22","current":67.096218,"twenty":-76.102676,"median":-31.546239,"eighty":115.492019,"marketCap":34421701930},{"date":"2026-05-29","current":62.970154,"twenty":-75.880486,"median":-30.693232,"eighty":115.373164,"marketCap":32304948475},{"date":"2026-06-05","current":60.662245,"twenty":-75.223997,"median":-29.59006,"eighty":115.163248,"marketCap":31120945098},{"date":"2026-06-12","current":56.401824,"twenty":-74.640704,"median":-29.253094,"eighty":114.989528,"marketCap":28935263747},{"date":"2026-06-18","current":56.924083,"twenty":-74.490547,"median":-29.223519,"eighty":114.833736,"marketCap":29203193149},{"date":"2026-06-26","current":59.667569,"twenty":-74.312777,"median":-29.026044,"eighty":114.683445,"marketCap":30610656318},{"date":"2026-07-02","current":63.004827,"twenty":-74.195313,"median":-28.914242,"eighty":114.357667,"marketCap":32322736319},{"date":"2026-07-10","current":65.624791,"twenty":-74.135535,"median":-28.781271,"eighty":113.811576,"marketCap":33666830293},{"date":"2026-07-17","current":68.786518,"twenty":-74.11053,"median":-28.668245,"eighty":113.265677,"marketCap":35288859332},{"date":"2026-07-24","current":70.81271,"twenty":-74.11053,"median":-28.275697,"eighty":112.626442,"marketCap":36328336476}],"updateTime":1785048440177},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1192093154","title":"Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1192093154","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192093154?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:24","pubTimestamp":1784895881,"startTime":"0","endTime":"0","summary":"The market faced significant headwinds as the heavyweight ChangXin Technology is set to list on the Shanghai Stock Exchange's STAR Market on July 27. Today, A-share turnover fell below 2 trillion...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1044875133.USD","BK1521","LU0293314216.USD","ONC","06160","BK1233","SG9999014674.SGD","LU0516422440.USD","LU1642822792.SGD","688008","BK1522","LU1226287792.SGD","00175","LU0348735423.USD","LU0320764599.SGD","LU1861219969.SGD","LU1993786604.SGD","IE00BVYPNQ40.USD","LU0955669360.SGD","BK1161","BK1616","LU1152091754.HKD","BK1572","IE00B031HY20.USD","688235","LU0149534421.HKD","IE00BZ08YT58.USD","LU0955648018.USD","SG9999004220.SGD","01117","LU0359201612.USD","IE00BGHQDM52.EUR","LU1770034418.SGD","LU1226288170.HKD","300433","LU0326950275.SGD","BK1594","LU1719994722.HKD","02388","LU0072913022.USD","LU0359202008.SGD","06613","06809","BK1511","03143","IE0008369823.USD","00981","IE00B0JY6N72.USD","BK1129","LU0501845795.SGD","BK1610","LU0516423174.USD","LU0588546209.SGD","LU0516422366.SGD","LU1251922891.USD","BK1231","BK1507","LU1328277881.USD","BK1583","LU0955623706.USD","LU1224444064.USD","688981","BK1212","LU1211504680.USD","LU0314109678.HKD","01093","LU1023057109.AUD","LU0140636845.USD","LU0052750758.USD","LU2328871848.SGD","BK1539","LU0607220059.USD","LU1969619763.USD","BK1515","BK1588","LU0067412154.USD","LU1226287875.USD","LU1303224171.USD","LU1807302812.USD","BK1587","EVS.SI","LU1282651121.HKD","BK1163","GELYY","LU0417516738.SGD","LU1044874839.SGD","BK1560","IE00BVYPNP33.GBP","BK1191","HK0000165453.HKD","LU0315179316.USD","LU1226288253.USD","SG9999002828.SGD","BK1553","LU0163747925.USD","LU1960683339.HKD","LU0738912210.USD","BK1601","LU1226287529.USD","BHKLY","BK1526","605198","LU0307460666.USD","603986","LU0708995583.HKD","02218","00023","BK1500","00189","BK1589","BK1119","LU1130305938.SGD","LU1152091168.USD","LU1813983027.USD","80175","LU0359201885.HKD","LU0516423091.SGD","LU1008478684.HKD","09863","IE00B5MMRT66.SGD","03986","LU0228367735.SGD","BK1607","LU1861214812.USD","BK1614","LU2039709279.SGD","02589","02513","KURE","LU1951186391.HKD","02356","BK1170","LU0593848301.USD","LU0880133367.SGD","LU1044876610.USD","IE00B543WZ88.USD","IE0008368742.USD","BK1237","LU0516422952.EUR","LU1328615791.USD","IE00BZ08YR35.GBP","LU2360107325.USD","BKEAY","IE00BZ08YS42.EUR","BK1117","LU0414403682.SGD","82388","LU1282651048.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145338164","title":"BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1145338164","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145338164?lang=en_us&edition=fundamental","pubTime":"2026-07-24 10:12","pubTimestamp":1784859132,"startTime":"0","endTime":"0","summary":"On July 24th, Hong Kong stocks fell again, with the Hang Seng Index dropping over 1%. Pharmaceutical stocks bucked the trend and moved higher, with innovative drug leaders pushing upward once more....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4585","ONC","BK1500","MEDX","LU1770034418.SGD","LU1969619763.USD","LU1251922891.USD","BK1588","LU2328871848.SGD","BK4588","159992","LU1303224171.USD","BK1583","LU0588546209.SGD","LU1719994722.HKD","BK0239","LNGR","520880","BK4526","06160","BK4139","FLHK","KURE","06978","BK1161","LU0307460666.USD","IBBQ","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653293727","title":"BeOne Medicines to Invest $300 Million to Expand US Drug Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653293727","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653293727?lang=en_us&edition=fundamental","pubTime":"2026-07-23 22:30","pubTimestamp":1784817036,"startTime":"0","endTime":"0","summary":"BeOne Medicines  said Thursday it plans to invest $300 million to expand its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus in Hopewell, New Jersey.The expansion will advance BeOne's oncology pipeline of more than 35 clinical and commercial-stage assets, the company said.The investment will fund the construction of a new three-story, 145,000-square-foot building near BeOne's existing Hopewell facilities, increasing the total campus footprint to about 545,000 square feet, the company added.Price: 322.62, Change: +2.69, Percent Change: +0.84","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ONC","BK4526","BK4139","BK4585","MDCO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172822449","title":"Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1172822449","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172822449?lang=en_us&edition=fundamental","pubTime":"2026-07-23 20:11","pubTimestamp":1784808697,"startTime":"0","endTime":"0","summary":"On July 22nd, a clinical trial registration platform showed that Amgen and BeiGene jointly registered a Phase III study, DeLLphi-315, comparing subcutaneous versus intravenous administration of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","IE0009355771.USD","LU0307460666.USD","LU2328871848.SGD","BK4585","IE00B4R5TH58.HKD","BK1161","BK4526","LU1969619763.USD","BK4139","III","LU1719994722.HKD","IBBQ","TBXU","LU0320765992.SGD","PBE","LU0109394709.USD","06160","IE00BJT1NW94.SGD","LU2242652126.USD","LU1770034418.SGD","BK1583","LU0588546209.SGD","LU1983299246.USD","BK1500","KURE","BK4581","LU2242646821.SGD","LU2112291526.USD","BK1588","BK0239","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4533","PJP","IE0002141913.USD","LU0889565916.HKD","BK4534","LU1023059063.AUD","IBB","BK4566","LU1251922891.USD","LU0289739699.SGD","ONC","BBH","LU0058720904.USD","SG9999001440.SGD","BK4588","IE00B2B36J28.USD","LU2468319806.SGD","BK4134","IE00BJJMRZ35.SGD","BK4599","AMGN","688235","LU1061106388.HKD","LU2089984988.USD","LU1303224171.USD","LU0122379950.USD","LU1057294990.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653353147","title":"3 U.S. Drug Manufacturing Stocks Investors Are Watching As Tariffs Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2653353147","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653353147?lang=en_us&edition=fundamental","pubTime":"2026-07-22 11:30","pubTimestamp":1784691011,"startTime":"0","endTime":"0","summary":"Tariffs on imported generic drugs are set to rise sharply over the next few years, and that kind of policy shock rarely stays contained to one corner of the market. For investors, the question is which U.S. pharmaceutical and biotech manufacturing stocks might stand to benefit if production shifts closer to home, and which could face new pressures through supply chain or pricing risks. This article looks at how the new tariff path could affect larger domestic drug manufacturers and contract...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/3-us-drug-manufacturing-stocks-investors-are-watching-as-tar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/3-us-drug-manufacturing-stocks-investors-are-watching-as-tar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4585","BK4211","BK4526","ADMA","BK4139","BLTE","ISBC","ONC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652139404","title":"Press Release: Beone Medicines to Announce Second Quarter 2026 Financial Results on August 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2652139404","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652139404?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:02","pubTimestamp":1784282520,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif.--(BUSINESS WIRE)--July 17, 2026--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on We","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCO","BK4139","ONC","BK4585","BK4588","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651544933","title":"BeOne Medicines (ONC) Stock Looks Expensive Even With Strong Pipeline Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2651544933","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651544933?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:33","pubTimestamp":1784198003,"startTime":"0","endTime":"0","summary":"BeOne Medicines has delivered a 61.1% return over the past three years, yet its current valuation screens as overvalued on market multiples and only middling on broader checks. This raises the question of how much optimism is already reflected in the share price.\n\nA 61.1% three year return suggests investors have already priced in a meaningful amount of good news for BeOne Medicines.\nRecent analyst upgrades tied to the chronic lymphocytic leukemia franchise and solid tumor pipeline can...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-onc-stock-looks-expensive-even-with-strong-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-onc-stock-looks-expensive-even-with-strong-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MDCO","ONC","BK4585","BK4588","BK4526","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651482014","title":"How Chemotherapy-Free Phase 3 MCL Success At BeOne Medicines (ONC) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482014","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482014?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:23","pubTimestamp":1784064190,"startTime":"0","endTime":"0","summary":"BeOne Medicines Ltd. recently reported positive topline results from its Phase 3 MANGROVE trial, where BRUKINSA (zanubrutinib) plus rituximab significantly improved progression-free survival versus bendamustine plus rituximab in previously untreated mantle cell lymphoma.\nThis is the first global Phase 3 study to show a chemotherapy-free, rituximab maintenance-free regimen can match or exceed standard chemoimmunotherapy, potentially sparing patients around two years of infusion treatment...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/how-chemotherapy-free-phase-3-mcl-success-at-beone-medicines","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/how-chemotherapy-free-phase-3-mcl-success-at-beone-medicines","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4526","BK4139","BK4585","ONC","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651150175","title":"BeOne Medicines (ONC) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2651150175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651150175?lang=en_us&edition=fundamental","pubTime":"2026-07-14 16:37","pubTimestamp":1784018241,"startTime":"0","endTime":"0","summary":"In a report released today, Etzer Darout from Barclays maintained a Buy rating on BeOne Medicines, with a price target of $403.00. Darout covers th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/beone-medicines-onc-gets-a-buy-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/beone-medicines-onc-gets-a-buy-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","ONC","BK4526","BK4585","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650750489","title":"BeOne Medicines Advances Sonrotoclax Formulation Study, Signaling Progress in ONC Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2650750489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650750489?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:31","pubTimestamp":1783614692,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines is running a Phase 1 study in healthy adults to test ho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-sonrotoclax-formulation-study-signaling-progress-in-onc-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-sonrotoclax-formulation-study-signaling-progress-in-onc-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ONC","PRGS","BK4097","BK4588","LU2065732104.USD","MDCO","BK4139","BK4526","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978219","title":"BeOne Medicines treatment of pancreatic cancer granted orphan status","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978219","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650978219?lang=en_us&edition=fundamental","pubTime":"2026-07-09 23:00","pubTimestamp":1783609213,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC)’ MTA-cooperative PRMT5 inhibitor was granted FDA orphan designation as a treatment of pancreatic cancer, according to a post ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-medicines-treatment-of-pancreatic-cancer-granted-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-medicines-treatment-of-pancreatic-cancer-granted-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","LABU","MDCO","ONC","BK4526","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124370507","title":"BEIGENE Awards Aggregate 33,400 Restricted Stock Units Represented by American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1124370507","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124370507?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:06","pubTimestamp":1783501565,"startTime":"0","endTime":"0","summary":"BEIGENE (HKEX: 06160) has announced that on July 2, 2026, the Compensation Committee of the Board of Directors, pursuant to the terms of the 2016 Option and Incentive Plan, granted a total of 33,400...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1719994722.HKD","06160","BK1500","LU1251922891.USD","LU1770034418.SGD","BK4585","LU0307460666.USD","LU1969619763.USD","BK0239","BK4526","LU0588546209.SGD","BK1161","BK4139","LU1303224171.USD","ONC","BK1588","688235","LU2328871848.SGD","BK1583","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163772490","title":"BEIGENE Shares Surge Over 4% on Positive Phase 3 Clinical Trial News for Zanubrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=1163772490","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163772490?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:43","pubTimestamp":1783042997,"startTime":"0","endTime":"0","summary":"Shares of BEIGENE (HKEX: 06160) rose more than 4% in early trading. At the time of writing, the stock was up 4.58% to HK$182.7, with a turnover of HK$81.56 million.The increase follows the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","LU1770034418.SGD","BK1588","688235","BK4588","BK4139","ONC","BK4585","LU2328871848.SGD","LU0588546209.SGD","LU0307460666.USD","BK0239","LU1303224171.USD","LU1969619763.USD","BK4526","BK1161","BK1500","06160","BK1583","LU1719994722.HKD","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648510936","title":"Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), BeOne Medicines (ONC) and Zevra Therapeutics (ZVRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648510936","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648510936?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:40","pubTimestamp":1782906024,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Jazz Pharmaceuticals (JAZZ), BeOne Medicines (ONC) a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jazz-pharmaceuticals-jazz-beone-medicines-onc-and-zevra-therapeutics-zvra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jazz-pharmaceuticals-jazz-beone-medicines-onc-and-zevra-therapeutics-zvra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN0W2T93.GBP","XLV","JAZZ","LU0889565916.HKD","LU0029874061.USD","IE00BN0W2V16.EUR","LU0109394709.USD","LU0154245756.USD","XBI","BK4588","HCSG","BK4526","BK4139","BK4532","MDCO","BK4007","BK4585","LU0128526141.USD","BK4533","LU0154245673.USD","LU0823416689.USD","LABU","BK4581","IE00BN0W2W23.USD","LU0320765992.SGD","ONC","BK4137","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183010146","title":"BEIGENE Reports Positive Phase 3 Trial Results for BRUKINSA® in First-Line Treatment of Mantle Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1183010146","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183010146?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:12","pubTimestamp":1782828767,"startTime":"0","endTime":"0","summary":"BEIGENE announced positive results from the MANGROVE Phase 3 clinical trial (BGB-3111-306;NCT04002297).The study evaluated its foundational, self-developed BTK inhibitor, BRUKINSA® (zanubrutinib),...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK1161","BK1583","BK1588","LU0588546209.SGD","LU2328871848.SGD","LU1969619763.USD","BK4526","BK4585","688235","LU1770034418.SGD","BK0239","LU1719994722.HKD","LU1303224171.USD","LU0307460666.USD","LU1251922891.USD","BK1500","ONC","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647453719","title":"BeOne Medicines' Potential Chemotherapy-Free Lymphoma Treatment Meets Primary Endpoint in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2647453719","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647453719?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:40","pubTimestamp":1782816030,"startTime":"0","endTime":"0","summary":"BeOne Medicines'  Brukinsa met its primary endpoint of progression-free survival in a phase 3 study evaluating the drug as a potential treatment in combination with rituximab for mantle cell lymphoma, the company said Tuesday.The chemotherapy-free drug combination showed \"a highly statistically significant and clinically meaningful improvement\" versus standard of care, the company said.The safety profile was consistent with that of both medicines, the company said.Mantle cell lymphoma is a rare and typically aggressive type of B-cell non-Hodgkin lymphoma, mostly affecting older adults, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO","ONC","BK4139","BK4585","BK4526","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327725","title":"Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647327725?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:33","pubTimestamp":1782725580,"startTime":"0","endTime":"0","summary":"Chinese biopharma stocks rallied on Monday, as investors moved away from artificial-intelligence stocks amid concerns over overstretched valuations.Shares of BeOne Medicines led gains among biopharma ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","00241","BK0028","LU1993786604.SGD","CHAT","IE00BPRC5H50.USD","BK0196","LU0456827905.SGD","LU0405327494.USD","LU1807302812.USD","AIPO","LU1255011170.USD","06618","LU1808992512.USD","603259","ARTY","BK0012","BK1191","LU1251922891.USD","BK0216","01093","BK4585","AGIX","86618","LU0140636845.USD","LU0315179316.USD","BK1571","BK0239","BK1189","BK1161","01877","09637","BK1502","HCSG","01801","ISBC","02315","LU1303224171.USD","ONC","IE00BZ08YS42.EUR","XLV","LU2328871848.SGD","LU1008478684.HKD","BK4137","LABU","BK1583","600276","LU1226287529.USD","LU2039709279.SGD","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125815089","title":"BEIGENE Subsidiary to Pay Approximately 446 Million Yuan in Back Taxes, No Penalty Involved","url":"https://stock-news.laohu8.com/highlight/detail?id=1125815089","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125815089?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:08","pubTimestamp":1782468514,"startTime":"0","endTime":"0","summary":"BEIGENE (ASX: 06160) has announced that a wholly-owned subsidiary in China has received and agreed to a notice from local tax authorities regarding adjustments to previously filed tax returns.The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","ONC","BK4585","LU1251922891.USD","LU1303224171.USD","LU1719994722.HKD","BK4588","LU1770034418.SGD","BK0239","BK1500","BK4526","688235","BK1161","LU0588546209.SGD","LU0307460666.USD","LU2328871848.SGD","BK4139","06160","BK1583","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646802037","title":"BeOne Medicines’ Real‑World Lung Cancer Study Puts Tislelizumab Under the Market Microscope","url":"https://stock-news.laohu8.com/highlight/detail?id=2646802037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646802037?lang=en_us&edition=fundamental","pubTime":"2026-06-26 00:31","pubTimestamp":1782405082,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines (ONC) is running an observational study called “A Real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-realworld-lung-cancer-study-puts-tislelizumab-under-the-market-microscope?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-realworld-lung-cancer-study-puts-tislelizumab-under-the-market-microscope?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4526","BK4588","BK4585","ONC","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644808016","title":"BeOne Medicines (ONC) Investors Track New Data from BeiGene’s Chronic Urticaria Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2644808016","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644808016?lang=en_us&edition=fundamental","pubTime":"2026-06-19 00:32","pubTimestamp":1781800347,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines (ONC) investors are watching a new update on a BeiGene ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-onc-investors-track-new-data-from-beigenes-chronic-urticaria-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-onc-investors-track-new-data-from-beigenes-chronic-urticaria-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BK4588","BK4139","MDCO","ONC","BK4526","BK4585","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":116,"code":"91000000","status":"200"}]}}